Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight-photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in 6 European countries
Journal of the European Academy of Dermatology and Venereology Nov 19, 2017
Fargnoli MC, et al. - The goal of this paper was to cumulate real-world clinical data on the use of methyl aminolevulinate daylight-photodynamic therapy (MAL DL-PDT) for the treatment of face and scalp actinic keratoses (AK) in Europe. The data disclosed that its use led to high levels of patient and physician satisfaction in clinical practice in Europe. This finding displayed the good efficacy and high tolerability of this convenient procedure.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries